Vir Biotechnology, Inc.VIRNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank88
5Y CAGR-8.4%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

5Y CAGR
-8.4%/yr
Long-term compound
Percentile
P88
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$45.85M-
2024$0.00-
2023$0.00-
2022$0.00-
2021$0.00-100.0%
2020$70.94M+88.7%
2019$37.60M+29.1%
2018$29.13M+34.3%
2017$21.69M-